Multiple Studies Help Define New Biomarkers for Myelodysplastic Syndromes
luvqs / Pixabay

Multiple Studies Help Define New Biomarkers for Myelodysplastic Syndromes

According to a story from Medpage Today, three recent research studies have managed to reveal new biomarkers for myelodysplastic syndromes. Biomarkers are a crucial factor for understanding a medical condition…

Continue Reading Multiple Studies Help Define New Biomarkers for Myelodysplastic Syndromes

A Study of an Investigational Acute Myeloid Leukaemia and Myelodysplastic Syndrome Drug Has Completed Enrolment

  The company Imago Biosciences, which focuses on developing anti-cancer therapies, is carrying out a Phase 1/2a clinical study of an investigational drug called IMG-7289 as a potential treatment for…

Continue Reading A Study of an Investigational Acute Myeloid Leukaemia and Myelodysplastic Syndrome Drug Has Completed Enrolment

Welcome AAMDS, a New Patient Worthy Advocacy Partner!

We're happy to introduce a new partner to Patient Worthy's mission of advocating for rare disease patients! The Aplastic Anemia and MDS International Foundation (AAMDS) supports, connects and educates patients, caregivers…

Continue Reading Welcome AAMDS, a New Patient Worthy Advocacy Partner!

Aplastic Anemia and MDS International Foundation’s Living with Aplastic Anemia, MDS, and PNH Conference

  • Post author:
  • Post category:

A patient and family conference for people with aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, and acute myeloid leukemia. Nurses, caregivers, or other health professionals are also encouraged to attend. Learn more…

Continue Reading Aplastic Anemia and MDS International Foundation’s Living with Aplastic Anemia, MDS, and PNH Conference

Aplastic Anemia and MDS International Foundation’s Living with Aplastic Anemia, MDS, and PNH Conference

  • Post author:
  • Post category:

A patient and family conference for people with aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, and acute myeloid leukemia. Nurses, caregivers, or other health professionals are also encouraged to attend. Learn more…

Continue Reading Aplastic Anemia and MDS International Foundation’s Living with Aplastic Anemia, MDS, and PNH Conference
A Treatment Trial Has Produced Promising Results in Patients With Myelodysplastic Syndromes
Source: Pixabay

A Treatment Trial Has Produced Promising Results in Patients With Myelodysplastic Syndromes

A press release from Aprea Theraputics has just announced the results of a Phase II clinical trial of the drug APR-246 in patients with myelodysplastic syndromes (a group of blood…

Continue Reading A Treatment Trial Has Produced Promising Results in Patients With Myelodysplastic Syndromes

Aplastic Anemia and MDS International Foundation’s Living with Aplastic Anemia, MDS, and PNH Conference

  • Post author:
  • Post category:

A patient and family conference for people with aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, and acute myeloid leukemia. Nurses, caregivers, or other health professionals are also encouraged to attend. Learn more…

Continue Reading Aplastic Anemia and MDS International Foundation’s Living with Aplastic Anemia, MDS, and PNH Conference